Here's How Henry Schein Is Placed Ahead of Q1 Earnings
HSIC heads into Q1 earnings results with steady estimates, a 5.1% revenue growth outlook and strength across distribution, specialty products and tech.
Is Agenus (AGEN) Outperforming Other Medical Stocks This Year?
Here is how Agenus (AGEN) and Apyx Medical (APYX) have performed compared to their sector so far this year.
Agenus (AGEN) is a Great Momentum Stock: Should You Buy?
Does Agenus (AGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Can Agenus (AGEN) Run Higher on Rising Earnings Estimates?
Agenus (AGEN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
All You Need to Know About Agenus (AGEN) Rating Upgrade to Strong Buy
Agenus (AGEN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why Agenus (AGEN) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Has Agenus (AGEN) Outpaced Other Medical Stocks This Year?
Here is how Agenus (AGEN) and Ensign Group (ENSG) have performed compared to their sector so far this year.
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript
Agenus Inc. (AGEN) Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives Transcript
Agenus Inc. (AGEN) Discusses Zydus Collaboration, Global Manufacturing Expansion, and Patient Access Initiatives Transcript
Agenus (AGEN) Upgraded to Buy: What Does It Mean for the Stock?
Agenus (AGEN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript
Agenus (AGEN) Misses Q3 Earnings and Revenue Estimates
Agenus (AGEN) came out with quarterly earnings of $1.94 per share, missing the Zacks Consensus Estimate of $2.63 per share. This compares to a loss of $3.17 per share a year ago.
